EUVIMEDEUVIMED entdecken
Crossref

Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study

Sibel Tekin, Roger Lane

Progress in Neurotherapeutics and Neuropsychopharmacology · 2006

DOI: 10.1017/s1748232105000030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Progress in Neurotherapeutics and Neuropsychopharmacology, 2006. Verfasst von Sibel Tekin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tekin, S., & Lane, R. (2006). Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study. Progress in Neurotherapeutics and Neuropsychopharmacology. https://doi.org/10.1017/s1748232105000030

Vancouver

Tekin S, Lane R. Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study. Progress in Neurotherapeutics and Neuropsychopharmacology. 2006. doi:10.1017/s1748232105000030

BibTeX
@article{Tekin2006,
  author = {Tekin, Sibel and Lane, Roger},
  title = {Rivastigmine in the Treatment of Dementia Associated with Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Study},
  journal = {Progress in Neurotherapeutics and Neuropsychopharmacology},
  year = {2006},
  doi = {10.1017/s1748232105000030}
}
Kostenlos starten →